A novel humanized antibody targeting CD39 that enhances anti-tumor immunity and the efficacy of cancer immunotherapy.

被引：0

作者：

Ban, Haruka ^{[1
]}

Obonai, Toshifumi ^{[1
]}

Mishima, Yuji ^{[1
]}

Matsumoto, Noriko ^{[1
]}

Mie, Motoya ^{[1
]}

Nakamura, Norihiro ^{[1
]}

机构：

[1] BrightPath Biotherapeut Co Ltd, Kawasaki, Kanagawa, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14508

引用

页数：1

共 50 条

[1] Preclinical development of a humanized blocking antibody targeting the CD39 immune checkpoint for cancer immunotherapy
Augier, Severine
Perrot, Ivan
Dejou, Cecile
Joly, Rachel
Delahaye, Stephane
Blanc, Helene Rispaud
Denis, Caroline
Gauthier, Laurent
Bensussan, Armand
Eliaou, Jean-francois
Morel, Yannis
Bonnefoy, Nathalie
Bastid, Jeremy
Paturel, Carine
CANCER RESEARCH, 2016, 76
[2] Novel anti-CD84 humanized monoclonal antibody enhances anti-tumor immunity in multiple myeloma
Gunes, Metin
Lewinsky, Hadas
Dang, Jessica
Ma, Ning
Vaidehi, Nagarajan
Janakiram, Murali
Feng, Mingye
Shachar, Idit
Rosen, Steven
Gunes, E. Gulsen
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S91 - S91
[3] Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
Kashyap, Abhishek S.
Thelemann, Tamara
Klar, Richard
Kallert, Sandra M.
Festag, Julia
Buchi, Melanie
Hinterwimmer, Lisa
Schell, Monika
Michel, Sven
Jaschinski, Frank
Zippelius, Alfred
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[4] AB598, A THERAPEUTIC ANTI-HUMAN CD39 ANTIBODY, BINDS AND INHIBITS CD39 ENZYMATIC ACTIVITY IN VIVO TO PROMOTE ANTI-TUMOR IMMUNITY
Parashar, Kaustubh
Clor, Julie
Anderson, Amy
Vani, Urvi
Singh, Jaskirat
Stagnaro, Enzo
Soriano, Ferdie
Kaplan, Angelo
Kline, Janine
Seitz, Lisa
Young, Stephen
Walker, Nigel
Walters, Matthew
Fernandez-Salas, Ester
Bowman, Christine
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1033 - A1033
[5] Targeting tumor cells with antibodies enhances anti-tumor immunity
Zhichen Sun
Yang-Xin Fu
Hua Peng
BiophysicsReports, 2018, 4 (05) : 243 - 253
[6] Inhibition of CD39 results in elevated ATP and activation of myeloid cells to promote anti-tumor immunity
Bowman, Christine E.
Chen, Ada
Juat, Damie
Parashar, Kaustubh
Clor, Julie
Singh, Hema
Kushwaha, Ritu
Handlos, Bryan
Liu, Suan
Kline, Janine
Zhao, Xiaoning
Kwon, Hyock Joo
Green, David
Young, Stephen W.
Fernandez-Salas, Ester
Walters, Matthew J.
Walker, Nigel P.
CANCER RESEARCH, 2022, 82 (12)
[7] Increasing Targeting and Efficacy of Anti-Tumor Antibody
McKetney, Justin
Kerr, Rebecca
Collins, Edward J.
BIOPHYSICAL JOURNAL, 2015, 108 (02) : 629A - 629A
[8] Phosphatidylserine-targeting antibody combined with chemoradiation enhances systemtic anti-tumor immunity
Wang, Yifan
Liu, Zhigang
Deng, Weiye
Kim, Betty Y.
Lin, Steven H.
Jiang, Wen
CANCER RESEARCH, 2019, 79 (13)
[9] Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Li, Xian-Yang
Moesta, Achim K.
Xiao, Christos
Nakamura, Kyohei
Casey, Mika
Zhang, Haiyan
Madore, Jason
Lepletier, Ailin
Aguilera, Amelia Roman
Sundarrajan, Ashmitha
Jacoberger-Foissac, Celia
Wong, Clifford
dela Cruz, Tracy
Welch, Megan
Lerner, Alana G.
Spatola, Bradley N.
Soros, Vanessa B.
Corbin, John
Anderson, Ana C.
Effern, Maike
Hoelzel, Michael
Robson, Simon C.
Johnston, Rebecca L.
Waddell, Nicola
Smith, Corey
Bald, Tobias
Geetha, Nishamol
Beers, Courtney
Teng, Michele W. L.
Smyth, Mark J.
CANCER DISCOVERY, 2019, 9 (12) : 1754 - 1773
[10] Expression of CD39 and CD73 as a means of evading anti-tumor immune reponses in lung cancer
Meyer, Christian
Rosinsky, Carolyn
Alme, Angela
Rowell, Jonathan
JOURNAL OF IMMUNOLOGY, 2010, 184

← 1 2 3 4 5 →